A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma as Compared With Standard of Care Therapies
Clinical trial NCT06592222 · COMPLETED
Trial details
- NCT number
- NCT06592222
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-08-26
- Primary completion
- 2025-03-03
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.